AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,039 | +36.2% | 720,101 | 0.0% | 0.02% | +33.3% |
| Q2 2023 | $2,232 | +165.4% | 720,101 | +19.0% | 0.02% | +150.0% |
| Q1 2023 | $841 | -17.1% | 605,202 | +18.8% | 0.01% | -14.3% |
| Q4 2022 | $1,014 | -96.4% | 509,507 | +3565.5% | 0.01% | – |
| Q3 2022 | $28,000 | -41.7% | 13,900 | -7.2% | 0.00% | – |
| Q2 2022 | $48,000 | -42.9% | 14,982 | -25.8% | 0.00% | – |
| Q1 2022 | $84,000 | -5.6% | 20,202 | +8.4% | 0.00% | – |
| Q4 2021 | $89,000 | +7.2% | 18,632 | +20.3% | 0.00% | – |
| Q3 2021 | $83,000 | +31.7% | 15,487 | +26.2% | 0.00% | – |
| Q2 2021 | $63,000 | -10.0% | 12,271 | +18.1% | 0.00% | – |
| Q1 2021 | $70,000 | -74.4% | 10,392 | -15.5% | 0.00% | -100.0% |
| Q3 2018 | $273,000 | +16.7% | 12,293 | -13.8% | 0.00% | +100.0% |
| Q2 2018 | $234,000 | – | 14,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |